Dermata Therapeutics Overview
Dermata Therapeutics Discounted Cash Flow
DCF Analysis for DRMA.
Get informed when a big investor buys or sells
+ FollowFair Value
$2.07
Current Fair Value
$2.07
↑ 72.2% Upside
Undervalued by 72.2% based on the discounted cash flow analysis.
Average Upside/Downside (Comparison Companies)
Fair Value vs. Stock Price History
Upside/Downside History
Upside/Downside Comparison